Takeda Pharmaceutical (TAK) Invested Capital: 2018-2025

  • Takeda Pharmaceutical's Invested Capital fell 8.21% to $75.1 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $75.1 billion, marking a year-over-year decrease of 8.21%. This contributed to the annual value of $75.2 billion for FY2025, which is 10.53% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Invested Capital of $75.1 billion as of Q1 2025, which was down 8.21% from $81.8 billion recorded in Q1 2024.
  • In the past 5 years, Takeda Pharmaceutical's Invested Capital registered a high of $92.7 billion during Q1 2021, and its lowest value of $75.1 billion during Q1 2025.
  • For the 3-year period, Takeda Pharmaceutical's Invested Capital averaged around $79.3 billion, with its median value being $81.2 billion (2023).
  • Per our database at Business Quant, Takeda Pharmaceutical's Invested Capital increased by 2.78% in 2021 and then dropped by 8.21% in 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Invested Capital (Quarterly) stood at $92.7 billion in 2021, then decreased by 6.89% to $86.3 billion in 2022, then declined by 5.96% to $81.2 billion in 2023, then rose by 0.74% to $81.8 billion in 2024, then dropped by 8.21% to $75.1 billion in 2025.
  • Its Invested Capital was $75.1 billion in Q1 2025, compared to $81.8 billion in Q1 2024 and $81.2 billion in Q1 2023.